Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9 | 5185581 | missense variant | A/T | snv | 2.1E-03 | 2.0E-03 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
1.000 | 0.080 | 9 | 5169600 | intron variant | C/T | snv | 2.5E-03 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
9 | 5140958 | intron variant | G/A | snv | 6.3E-05 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
1.000 | 0.040 | 9 | 5126768 | missense variant | A/G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 9 | 5126715 | missense variant | A/G | snv | 2.0E-03 | 2.1E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.040 | 9 | 5126343 | missense variant | G/A;C | snv | 4.4E-03 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 9 | 5126343 | missense variant | G/A;C | snv | 4.4E-03 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 9 | 5112288 | non coding transcript exon variant | C/T | snv | 0.51 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 9 | 5090497 | missense variant | G/A | snv | 1.4E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
9 | 5089770 | missense variant | G/A | snv | 1.7E-05 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.040 | 9 | 5084049 | intron variant | G/A;T | snv | 0.63 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 9 | 5084049 | intron variant | G/A;T | snv | 0.63 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 9 | 5081828 | missense variant | G/C | snv | 4.2E-04 | 5.4E-04 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
1.000 | 0.040 | 9 | 5081828 | missense variant | G/C | snv | 4.2E-04 | 5.4E-04 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 9 | 5081780 | synonymous variant | G/A | snv | 0.53 | 0.62 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.851 | 0.120 | 9 | 5081780 | synonymous variant | G/A | snv | 0.53 | 0.62 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.851 | 0.120 | 9 | 5081780 | synonymous variant | G/A | snv | 0.53 | 0.62 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.851 | 0.120 | 9 | 5081780 | synonymous variant | G/A | snv | 0.53 | 0.62 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
9 | 5080657 | missense variant | G/A;C | snv | 1.3E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.925 | 0.120 | 9 | 5078395 | missense variant | C/G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |